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COST-EFFECTIVENESS ANALYSIS OF ARTHROSCOPIC SURGERY
COMPARED TO NON-OPERATIVE MANAGEMENT FOR
OSTEOARTHRITIS OF THE KNEE
J. Marsh y, T.B. Birmingham y, J.R. Gifﬁn y, W. Isaranuwatchai z,
J.S. Hoch z, R. Litchﬁeld y, K. Willits y, P. Fowler y. yWestern Univ., London,
ON, Canada; z St. Michael's Hosp., Toronto, ON, Canada
Purpose: Arthroscopic debridement and partial resection of degener-
ative joint tissues in patients with knee osteoarthritis (OA) is frequently
performed, yet its value is highly debated. The purpose of the present
analysis was to determine the cost-effectiveness of arthroscopic surgery
compared to non-operative treatment for knee OA.
Methods: The present data were collected as part of a previously
reported randomized controlled trial. Patients with knee OA were
randomly assigned to arthroscopic surgery combined with optimized
physical and medical therapy or to treatment with physical and medical
therapy alone, and were followed for two years. We used the WOMAC
total score and the quality-adjusted life year (QALY) at two years post-
operative as the effectiveness measures in our cost-effectiveness anal-
ysis. We recorded the total costs for each intervention, as well as all
health care resource use at each follow up appointment. All costs are
presented in 2012 Canadian dollars. We conducted a cost-effectiveness
analysis from a public health payer perspective and a societal per-
spective. We calculated the incremental cost-effectiveness ratio (ICER),
the incremental cost-utility ratio (ICUR), and estimated cost-effective-
ness using the net beneﬁt regression framework.
Results: A total of 169 patients were included in the cost-effectiveness
analysis (88 arthroscopy group, 81 non-operative group). Patients
allocated to the arthroscopy group received partial resection of
degenerative meniscal tears (81%) and/or debridement of degenerative
articular cartilage (97%). The ICER was $13,010 (CAN) (societal), or
$11,058 (CAN) (payer) for a clinically important improvement on the
WOMAC total score. The ICUR was $107,325 (CAN) (societal) or $91,230
(CAN) (payer) per QALY gained. The incremental net beneﬁt was neg-
ative for all willingness-to-pay values, from both the healthcare payer
and societal perspectives, suggesting that arthroscopic surgery is not
cost-effective compared to non-operative management.
Conclusions: The results of the present analysis suggest that arthro-
scopic debridement for the treatment of knee OA is not cost-effective
compared to non-operative management, in terms of disease-speciﬁc
quality of life and quality adjusted life years, from both a healthcare
payer and societal perspective.
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SUPPRESSION OF REDD1 IN OA CARTILAGE, A NOVEL MECHANISM
FOR DYSREGULATED MTOR ACTIVATION
O. Alvarez-Garcia, R. Akagi, Y. Akasaki, K.M. Fisch, A.I. Su, M.K. Lotz. The
Scripps Res. Inst., La Jolla, CA, United States
Purpose: Aging is a main risk factor for the development of osteo-
arthritis (OA) and the molecular mechanisms underlying the aging-
related changes in articular cartilage are beginning to be elucidated.
Using genome wide transcriptomic analysis, we identiﬁed the PI3K/Akt/
mTOR pathway as one of the most dysregulated pathways in OA carti-
lage, and REDD1, a regulator of cellular stress responses, as the most
suppressed gene in this pathway. The PI3K/Akt/mTOR signaling pathway
is a major driver of aging in model organisms and its role in OA patho-
genesis is emerging with abnormal mTOR activation becoming recog-
nized as an important dysfunction in OA chondrocytes. Therefore, the
present study analyzed REDD1 expression in normal and OA cartilage
and assessed REDD1 function in cultured human articular chondrocytes.
Methods: REDD1 expression was measured in articular cartilage
obtained from young healthy donors (38±13 years) or OA donors
undergoing knee replacement surgery (71±10 years) by qPCR and
immunohistochemistry. For in vitro studies, normal articular chon-
drocytes were treated with IGF-1, speciﬁc inhibitors of the PI3K/Akt/
mTOR and ERK pathways, in the presence or absence of REDD1 speciﬁc
siRNA. REDD1 expression, intracellular signaling pathway activation,
and autophagy weremeasured bywestern blot using antibodies against
REDD1, phospho-AKT, AKT, phospho-ERK, ERK, phospho-S6, S6, phos-
pho-4EBP and LC3, respectively.
Results: Human cartilage from normal knee joints expressed high levels
of REDD1 mRNA and protein. Immunohistochemistry showed predom-
inant REDD1 expression in the superﬁcial and upper-mid zones ascompared with the deep zone of the cartilage. REDD1 expression was
signiﬁcantly reduced in OA cartilage at both mRNA and protein levels. In
cultured chondrocytes, REDD1 protein expression was increased by
serum and IGF-1 treatment. IGF-1-induced REDD1 expression was
blocked by PI3K and mTOR inhibitors, but not by ERK inhibitors. REDD1
knockdown using siRNA resulted in increased S6 and 4EBP phosphor-
ylation, markers of increased mTOR activation. Finally, REDD1 knock-
downdecreased theLC3-II/GAPDHratio inhumanarticularchondrocytes.
Conclusions: The present study shows that REDD1 is highly expressed
in normal human articular cartilage and reduced in OA. Loss of REDD1
in human chondrocytes increases mTOR activity and decreases
autophagy activation. Collectively, these results suggest that REDD1 is
an important regulator of chondrocyte intracellular signaling andmTOR
inhibitor. Reduced REDD1 expression represents a novel mechanism for
the increased mTOR activation observed in OA.
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THE HARWELL AGEING SCREEN: A DISCOVERY PLATFORM FOR
GENES AND PATHWAYS ASSOCIATED WITH AGE-RELATED DISEASE
A. Blease y, M.E. Goldsworthy y, A. Haynes y, L. Wisby y, T. Nicol y,
S. Falcone y, H. Lad y, T. Vincent z, S.D. Brown y, P.K. Potter y. yMammalian
Genetics Unit, MRC Harwell, United Kingdom; zARUK Ctr. for OA
Pathogenesis, Kennedy Institute of Rheumatology, United Kingdom
Purpose: Diseases associated with ageing pose an increasing social and
ﬁnancial burden on society and represent an imperative for research in
the biomedical sciences. Despite the complications of genetic back-
ground in human populations and the confounds of environment, there
have been considerable advances, particularly through Genome-wide
association studies (GWAS) in identifying loci involved in diseases of
ageing. Nevertheless, this is only a ﬁrst step towards a more funda-
mental understanding of the genetic pathways involved. Animal models
are required both to test our understanding of these pathways, as well
as to provide the tools for developing and assessing therapeutics. We
are undertaking the ﬁrst large-scale project to investigate the inter-
action between genetic variation and the pleiotropic effects of ageing.
Methods: We are employing mutagenesis and phenotyping to speciﬁ-
cally generatenewmousemodels of late onset or age-related disease. The
emphasis is on the exploration of the phenotype space in ageing mouse
mutant populations providing us with the opportunity to: identify genes
and pathways involved in age related disease, scrutinise thesemodels for
biomarkers of age related disease, and provide better platforms for pre-
clinical assessmentof new therapies for suchdiseases. Pedigrees are aged
to 18 months and undergo comprehensive phenotyping across a wide
range of disease areas at several time points throughout the life of the
mice. Mutations are mapped initially by a dense SNP panel and then
individual mutations identiﬁed by whole genome sequencing.
Results: To date we have identiﬁed lines with age-related hearing loss,
cardiovascular disease, retinal degeneration, neurodegeneration, obe-
sity, and bone disease which are being mapped and characterised in
detail. We have identiﬁed two lines with late onset osteoarthritis. MP-
107 was identiﬁed as having mild skeletal abnormalities, particularly a
curved and wider ischium at 4 months of age. Upon ageing affected
mice developed increased boney deposits at the joints, identiﬁed by X
ray, and upon histopathological analysis showed osteophyte formation
and cartilage erosion. This line was mapped as a dominant phenotype
and localised to chromosome 11. An existing line (TM-44) also displayed
similar ischium abnormalities and also maps to chromosome 11. Whole
genome sequencing of MP-107 identiﬁed a non-synonymous change
(T304M) in ST6galnac2 (ST6(alpha-N-acetyl-neuraminyl-2,3-beta-gal-
actosyl-1,3)-N-acetylgalactosaminide alpha-2, 6-sialyltransferase 2). A
detailed time course of the pathogenesis of disease and functional
pathways is now underway in these lines to conﬁrm ST6galnac2T304M
as the causative mutation. In the pedigree MPC-227 mice were identi-
ﬁed with severe joint deterioration by 15 months of age. The causative
mutation was mapped to a missense mutation (A1946V) in aggrecan
(Acan). In addition to the joint deterioration these mice exhibited
quantitative and qualitative differences in brown and white adipose
tissue with ageing, resulting in obesity in ageing mutant mice. Acan
mutations in humans have been associated with an increased incidence
of osteoarthritis in humans and this mutant line will allow the inves-
tigation of pathogenic pathways associated with Acan abnormalities.
We are also investigated the role of Acan in adipose tissue.
Conclusions: The age challenged mice are an important resource for
many research groups, identifying novel genes and pathways resulting
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osteoarthritis, both with pleiotropic effects, and are characterising the
pathogenic pathways in detail. In addition to characterising disease
phenotypes we are now beginning to screen for advantageous or
healthy ageing phenotypes.
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COMPREHENSIVE TRANSCRIPTOME ANALYSIS OF AGING-RELATED
GENE EXPRESSION IN EARLY PHASE OF POST-TRAUMATIC
OSTEOARTHRITIS
T. Fukui y, A.B. Castillo z, J.H. Yik y, D.R. Haudenschild y. y Lawrence J.
Ellison Musculoskeletal Res. Ctr., Sacramento, CA, United States; zDept.
of Mechanical and Aerospace Engineering, New York Univ., New York,
NY, USA
Purpose: Risk factors for OA include age and a history of joint trauma.
Age-related changes in the joint occur independent of osteoarthritis,
but these underlying differences may affect OA development after
injury. The age-related differences in the response to joint injury and
post-traumatic OA (PTOA) development remain largely unknown,
especially during the early phase of injury. The aim of this study is to
elucidate the aging-related changes in early gene expression in
response to knee injury using a comprehensive transcriptome analysis.
Methods:
 Animal model of joint injury
Male C57BL/6 mice (12-weeks old as young) and (54-weeks old as old
age group) were used (n¼8 per group). The right knees were injured
with a single mechanical compression, which causes a transient ante-
rior subluxation of the tibia leading to PTOA within 8 weeks. The knees
were harvested 7 days after injury and RNA was extracted.
 Microarray analysis
Total RNA was hybridized to an Affymetrix GeneChip®Mouse Gene 1.0
ST Array. For analysis, GeneSpring software was used with all gene
expression values for unsupervised clustering of the arrays and prin-
cipal components analysis. Genes that were differentially expressed
(p<0.05) and showed signiﬁcant differences between two speciﬁed
groups (age, injury response in young, or injury response in old) were
identiﬁed. Genes with more than 1.5-fold difference were selected and
used for hierarchical clustering and functional analyses.
Results:
 Transcriptome analysis
Unsupervised clustering of all data showed that the gene expression
patterns agreed well with both the injury status and age of the mice, as
shown by the principal component analysis (Fig1A). We next compared
speciﬁc experimental groups to identify genes differentially regulated
by age (Old Uninjured vs. Young Uninjured, OU v YU), by injury in young
mice (YU vs. Young Injured, YU v YI), and by injury in old mice (OU vs.
OI), revealing approximately 7500 genes regulated by age, 3700 genes
regulated by injury in young mice, and 6000 genes regulated by injury
in old mice (Fig 1B).
 Comparative analysis between old and young uninjured knees
Hierarchical clustering of genes differentially regulated with age are
shown in Fig2A. Of the 273 differentially regulated genes, 188 were up-
regulated and 85 were down-regulated in OU against YU. (Fig1B) The
top 5 genes with the highest absolute fold change in expression (Fig 2B)
included anabolic genes that were down-regulated by aging, and genes
related to signal transduction that were up-regulated by aging. The top
10 diseases associated with these differentially regulated genes are
shown (Fig2C).
 Injury response in old and young mice
Comparative analysis between injured knees vs. uninjured knees in old
and young mice identiﬁed 511 genes that were up-regulated and 28
genes down-regulated by injury in old mice, and 323 genes up-regu-
lated and 30 genes down-regulated in young mice (Fig1B). 218 and 34
genes were regulated by injury speciﬁcally in old and young mice,
respectively (Fig3). The top 5 genes up- or down-regulated differentially
in only old or young mice are listed (Fig 3).
Conclusions: A comparison of old and young uninjured knees shows
that the up-regulated genes in old mice are mostly related to intra-
cellular signal transduction, while up-regulated genes in young mice
include the expression of extracellular matrix components such as col-
lagens. This suggests that youngmice have higher basal anabolic activity.
In response to injury, these anabolic genes were up-regulated more in
the old injured mice when calculated as a fold-change with respect to
the contralateral uninjured knee. This indicates that the anabolicresponse to injury is larger in old mice, perhaps to compensate for their
lower basal expression. However, despite an increased injury response in
old mice, the absolute levels of these anabolic genes are still lower than
in young mice. In summary, our results suggest that the capacity to
mount an anabolic response to injury is diminished in old age perhaps
due to age-related reduction in the basal level of anabolic genes.
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MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) PROMOTE
HYPEROXIDATION OF PEROXIREDOXINS AND INHIBIT PRO-
SURVIVAL IGF-1 SIGNALING IN HUMAN ARTICULAR CHONDROCYTES
J.A. Collins y, L. Poole z, C. Furdui z, K. Nelson z, R. Loeser y. yUniv. of North
Carolina at Chapel Hill, Chapel Hill, NC, United States; zWake Forest Sch. of
Med., Winston-Salem, NC, United States
Purpose:Mitochondrial dysfunction resulting in overproduction of ROS
is implicated in age-related conditions, including osteoarthritis, although
the mechanisms responsible are incompletely understood. The intra-
cellular redox balance ismaintained by antioxidant enzymes that include
the peroxiredoxins (PRXs). Oxidative stress occurs when an imbalance in
ROS production and removal disrupts normal cell signaling. ROS inhib-
ition of IGF-1 mediated phosphorylation of the pro-survival protein Akt
can result in cell death. The purpose of this study was to examine if
mitochondrial ROS overproduction reduced chondrocyte cell viability by
altering chondrocyte PRX redox status and IGF-1-Akt signaling.
Methods: Primary chondrocytes isolated from normal human articular
cartilage from donors aged 27 to 70 yrs were cultured in monolayer and
made serum-free prior to experiments. Chondrocytes were treated with
25 mM menadione to induce mitochondrial ROS and were transduced
with an adenoviral vector encoding catalase targeted to the mitochon-
dria (MCAT) to reduce levels of mitochondrial ROS or an empty vector
control. Cell viability was assessed using the Live/Dead cell assay.
